Publishing research using ab26696? Please let us know so that we can cite the reference in this datasheet.

ab26696 has been referenced in 15 publications.

  • Lee CK  et al. Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death. Oncogene 35:1988-95 (2016). PubMed: 26212014
  • Bartesaghi S  et al. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells. Proc Natl Acad Sci U S A 112:1059-64 (2015). WB . PubMed: 25583481
  • Shai A  et al. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Res 75:3167-80 (2015). WB . PubMed: 26001956
  • Zhang Q  et al. The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation. Nat Immunol 16:458-66 (2015). PubMed: 25799126
  • Takeda S  et al. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription. J Clin Invest 125:1203-14 (2015). PubMed: 25664857
  • Miceli AP  et al. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint. Mol Cell Biol 32:348-64 (2012). ICC/IF . PubMed: 22064482
  • Parikh N  et al. Mouse Tissues that Undergo Neoplastic Progression after K-Ras Activation Are Distinguished by Nuclear Translocation of phospho-Erk1/2 and Robust Tumor Suppressor Responses. Mol Cancer Res 10:845-55 (2012). WB . PubMed: 22532587
  • Saporita AJ  et al. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. Cancer Res 71:6708-17 (2011). WB ; Mouse . PubMed: 21937682
  • Ulanet DB & Hanahan D Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms. PLoS One 5:e12454 (2010). WB ; Mouse . PubMed: 20805995
  • den Besten W  et al. Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein. Cell Cycle 4: (2005). PubMed: 16205118
  • Korgaonkar C  et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25:1258-71 (2005). PubMed: 15684379
  • Silva RL  et al. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBO J 24:2803-14 (2005). PubMed: 16037818
  • Tago K  et al. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci U S A 102:7689-94 (2005). PubMed: 15897463
  • Kuo ML  et al. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 18:1862-74 (2004). PubMed: 15289458
  • Bertwistle D  et al. Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein. Hybrid Hybridomics 23:293-300 (2004). PubMed: 15672607


Sign up